Currently diagnosing RA is primarily based on clinical symptoms and the presence of various serum autoantibodies including rheumatoid factor (RF) and anti-citrullinated protein antibody (ACPA) [1–3]. Here, PRTN3 is linked to rheumatoid arthritis.